QT interval time lag in response to heart rate changes during stress test for Coronary Artery Disease diagnosis

Pérez, Cristina; Pueyo, Esther; Martínez, Juan Pablo; Viik, Jari; Laguna, Pablo

doi:10.1016/j.bspc.2023.105056

Cited by 4 publications

(1 citation statement)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Cardiovascular diseases (CVDs) have been identified as the leading cause of mortality globally by the World Health Organization (WHO), Pérez et al [ 1 ]. Coronary artery disease (CAD), primarily caused by atherosclerosis, occurs when plaque accumulates within the coronary arteries, leading to partial or complete blood flow restriction and subsequent reduction in oxygen and nutrient supply to the myocardium [ 2 ].…”

Section: Introductionmentioning

confidence: 99%

Genetic and clinical study of myeloperoxidase's association with coronary artery disease

Adam,

Al-Habib,

Oraha

et al. 2024

Egypt Heart J

View full text Add to dashboard Cite

Background Unraveling myeloperoxidase’s (MPO) correlation with coronary artery disease (CAD) and genetic variations, this study seeks to enhance diagnostic precision and therapeutic strategies. Results CAD patients were found to be older and more male than controls. Several clinical parameters, including glucose, total bilirubin, alkaline phosphatase, creatinine, and troponin levels, showed significant variations. Moreover, CAD patients had lower red cell distribution width (RDW%) and mean platelet volume (MPV) than controls. Serum MPO levels did not differ significantly between CAD patients and controls, and no correlation was found with other clinical parameters except for glucose, creatinine, and total bilirubin. Conclusions The data suggest that serum MPO levels are not substantially related to CAD patients, as indicated by lower MPO levels in CAD patients compared to controls. While highlighting the potential of MPV and RDW% as predictors of severe atherosclerosis in CAD. Further research is needed to validate the diagnostic and prognostic value of RDW%, MPV, and MPO levels in CAD. Trial registration: 15092021-9-12. Registered 15 September 2021.

show abstract

Section: Introductionmentioning

confidence: 99%